144 related articles for article (PubMed ID: 9184608)
21. [Valproate sodium and zonisamide associated interstitial pneumonitis in an infant].
Nikaido K; Kato T; Takayama R; Doi T
No To Hattatsu; 2007 Jan; 39(1):44-8. PubMed ID: 17228818
[TBL] [Abstract][Full Text] [Related]
22. IgG subclass levels and southern analysis of DNA in primary immunodeficiency diseases including IgG subclass deficiency.
Miwa Y; Inoue R; Ozawa T; Kondo N; Orii T
Exp Clin Immunogenet; 1994; 11(4):173-81. PubMed ID: 7857662
[TBL] [Abstract][Full Text] [Related]
23. Serum immunoglobulin and immunoglobulin G subclasses in children with allergic colitis.
Ojuawo A; Milla PJ; Lindley KJ
West Afr J Med; 1998; 17(3):206-9. PubMed ID: 9814094
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin G (IgG) subclasses and human disease.
Oxelius VA
Am J Med; 1984 Mar; 76(3A):7-18. PubMed ID: 6369977
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility to infections in children with selective IgA- and IgA-IgG subclass deficiency.
Morell A; Muehlheim E; Schaad U; Skvaril F; Rossi E
Eur J Pediatr; 1986 Aug; 145(3):199-203. PubMed ID: 3769975
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
[TBL] [Abstract][Full Text] [Related]
27. Reversible total IgA deficiency associated with phenytoin treatment.
Braconier JH
Scand J Infect Dis; 1999; 31(5):515-6. PubMed ID: 10576137
[TBL] [Abstract][Full Text] [Related]
28. Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.
White JR; Walczak TS; Marino SE; Beniak TE; Leppik IE; Birnbaum AK
Neurology; 2010 Aug; 75(6):513-8. PubMed ID: 20697103
[TBL] [Abstract][Full Text] [Related]
29. IgG subclass deficiency in children with IgA deficiency presenting with recurrent or severe respiratory infections.
Beard LJ; Ferrante A; Oxelius VA; Maxwell GM
Pediatr Res; 1986 Oct; 20(10):937-42. PubMed ID: 3774407
[TBL] [Abstract][Full Text] [Related]
30. Smoldering myeloma associated with zonisamide treatment.
Asai S; Miyachi H; Kobayashi H; Hotta T; Ando Y
Intern Med; 2002 Feb; 41(2):138-41. PubMed ID: 11868602
[TBL] [Abstract][Full Text] [Related]
31. An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections.
French MA; Harrison G
Clin Exp Immunol; 1986 Dec; 66(3):640-7. PubMed ID: 3568451
[TBL] [Abstract][Full Text] [Related]
32. Zonisamide monotherapy in newly diagnosed infantile spasms.
Suzuki Y; Nagai T; Ono J; Imai K; Otani K; Tagawa T; Abe J; Shiomi M; Okada S
Epilepsia; 1997 Sep; 38(9):1035-8. PubMed ID: 9579944
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies in patients with IgA and IgG2 deficiencies.
Jiménez A; Alvarez-Doforno R; García Rodríguez MC; Ferreira A; López-Trascasa M; Fontán G
APMIS; 1991 Apr; 99(4):327-32. PubMed ID: 2036215
[TBL] [Abstract][Full Text] [Related]
34. Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency.
Carvalho Neves Forte W; Ferreira De Carvalho Júnior F; Damaceno N; Vidal Perez F; Gonzales Lopes C; Mastroti RA
Allergol Immunopathol (Madr); 2000; 28(1):18-20. PubMed ID: 10757854
[TBL] [Abstract][Full Text] [Related]
35. [Urolithiasis induced by combined ACTH and zonisamide treatment in a patient with startle induced epilepsy].
Saito Y; Yanagaki S; Oguni H; Hayashi K; Katsumori H; Nagafuchi H; Jo K; Osawa M
No To Hattatsu; 2002 Sep; 34(5):415-20. PubMed ID: 12233054
[TBL] [Abstract][Full Text] [Related]
36. Zonisamide.
Seino M; Miyazaki H; Ito T
Epilepsy Res Suppl; 1991; 3():169-74. PubMed ID: 1777076
[No Abstract] [Full Text] [Related]
37. Long-term retention rate of zonisamide in patients with epilepsy: an observational study.
Kim DW; Choi K; Moon HS; Oh J
Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169
[TBL] [Abstract][Full Text] [Related]
38. Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.
Kwan SY; Chuang YC; Huang CW; Chen TC; Jou SB; Dash A
CNS Neurosci Ther; 2015 Sep; 21(9):683-91. PubMed ID: 26205514
[TBL] [Abstract][Full Text] [Related]
39. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy.
Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Ig subclass deficiency: First reported case of IgG2, IgG4, and IgA deficiency caused by deletion of C alpha 1, psi C gamma, C gamma 2, C gamma 4, and C epsilon in a Mongoloid patient.
Terada T; Kaneko H; Li AL; Kasahara K; Ibe M; Yokota S; Kondo N
J Allergy Clin Immunol; 2001 Oct; 108(4):602-6. PubMed ID: 11590388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
